Medicare premiums and deductibles have increased for all retirees. There's now a $2,000 cap on annual out-of-pocket prescription drug costs. Some Medicare services, like telehealth, have gotten more restrictive in 2025.
Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services confirmed Friday.
The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf
A new wave of Medicare drug price negotiations could severely affect pharmacy services for seniors in long-term care facilities, according to the Senior Care Pharmacy Coalition (SCPC). The Biden administration announced Friday that it added 15 medications to the negotiation list,
Dear Toni, I had no problem opening the "My Social Security" account to enroll in Medicare because I knew those answers.
President-elect Donald Trump says he “most likely” will give TikTok 90 more days to work out a deal that would allow the popular video-sharing platform to avoid a U.S. ban.